Skip to main navigation Skip to search Skip to main content

Levodopa-Induced Hyperhomocysteinemia and Cardiovascular Dysfunction in Parkinson’s Disease

Research output: Contribution to conferencePresentation

Abstract

This presentation was given at the Movement Disorder Society International Congress of Parkinson’s Disease and Movement Disorders.
Original languageAmerican English
StatePublished - Jun 15 2004
EventMovement Disorder Society International Congress of Parkinson’s Disease and Movement Disorders (MDS) - Rome, Italy
Duration: Jun 15 2004 → …

Conference

ConferenceMovement Disorder Society International Congress of Parkinson’s Disease and Movement Disorders (MDS)
Period06/15/04 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Disciplines

  • Public Health
  • Epidemiology

Keywords

  • Cardiovascular dysfunction
  • Hyperhomocysteinemia
  • Levodopa-induced
  • Parkinson's disease

Fingerprint

Dive into the research topics of 'Levodopa-Induced Hyperhomocysteinemia and Cardiovascular Dysfunction in Parkinson’s Disease'. Together they form a unique fingerprint.

Cite this